Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LIPG | Q9Y5X9 | 13/20 | 0.74 |
| ▸ | LPL | P06858 | 12/20 | 0.74 |
| ▸ | P4HB | P07237 | 1/20 | 0.47 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.41 |
| ▸ | CA1 | P00915 | 2/20 | 0.40 |
| ▸ | CA2 | P00918 | 2/20 | 0.40 |
| ▸ | CA9 | Q16790 | 2/20 | 0.40 |
| ▸ | CA12 | O43570 | 1/20 | 0.40 |
| ▸ | CA3 | P07451 | 1/20 | 0.40 |
| ▸ | CA4 | P22748 | 1/20 | 0.40 |
| ▸ | CA6 | P23280 | 1/20 | 0.40 |
| ▸ | CA5A | P35218 | 1/20 | 0.40 |
| ▸ | CA7 | P43166 | 1/20 | 0.40 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.40 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.40 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.39 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.39 |
| ▸ | F11 | P03951 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21624614 | 0.97 | LIPG (0.74) | LIPGLPLP4HBDGAT1CA1 | |
| SCHEMBL21416280 | 0.95 | LIPG (0.77) | LIPGLPLP4HBDGAT1CA1 | |
| SCHEMBL1509154 | 0.95 | LIPG (0.77) | LIPGLPLP4HBDGAT1CA1 | |
| SCHEMBL22722776 | 0.93 | LIPG (0.85) | LIPGLPLP4HBDGAT1CA1 | |
| SCHEMBL19858597 | 0.93 | LIPG (0.85) | LIPGLPLP4HBDGAT1CA1 | |
| SCHEMBL13855173 | 0.91 | LIPG (0.70) | LIPGLPLP4HBDGAT1CA1 | |
| SCHEMBL20161075 | 0.90 | LIPG (0.60) | LIPGLPLP4HBDGAT1CA1 | |
| SCHEMBL21304574 | 0.86 | LIPG (0.64) | LIPGLPLP4HBDGAT1CA1 | |
| SCHEMBL17701207 | 0.86 | LIPG (0.69) | LIPGLPLP4HBDGAT1CA1 | |
| SCHEMBL17539979 | 0.86 | LIPG (0.64) | LIPGLPLP4HBDGAT1CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160118598-A1 | ELECTRON TRANSPORT MATERIAL AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME | JNC CORPORATION (JP) | 2016-04-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160118598-A1 | ELECTRON TRANSPORT MATERIAL AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME | HVCN1, VDAC1, SLC26A3 | LIPG 2977/4885LPL 3253/4885P4HB 2301/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.